Advertisement
Research Article| Volume 11, ISSUE 4, P451-456, August 1983

Prostacyclin-formation by the rabbit aorta: Relation to atherosclerosis

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The Prostacyclin(PGI2)-formation of the aortic vessel wall of normal and of atherosclerotic rabbits was measured by punching out and incubating small pieces of the vessel wall. In atherosclerotic rabbits the pieces taken from plaques produced more PGI2 than pieces taken from normal areas nearby. In addition, distinct differences were seen between different regions of the aorta. An investigation in normal rabbits of the regional distribution of the PGI2-producing capacity between the aortic valve and the bifurcation showed the highest production at places where the earliest and most severe atherosclerotic changes were observed in the atherosclerotic animals.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dembinska-Kiec A.
        • Gryglewska T.
        • Zmuda A.
        • Gryglewski R.J.
        The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits.
        Prostaglandins. 1977; 14: 1025
        • Gryglewski R.J.
        • Bunting S.
        • Moncada S.
        • Flower R.J.
        • Vane J.R.
        Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
        Prostaglandins. 1976; 12: 685
        • Gryglewski R.J.
        • Dembinska-Kiec A.
        • Zmuda A.
        • Gryglewska T.
        Prostacyclin and Thromboxane A2 biosynthesis capacities of heart. arteries and platelets at various sta ges of experimental atherosclerosis in rabbits.
        Atherosclerosis. 1978; 31: 385
        • Gryglewski R.J.
        Prostacyclin and atherosclerosis.
        TIPS February. 1980; 164
        • Harrison H.E.
        • Reece A.H.
        • Johnson M.
        Decreased vascular prostacyclin in experimental diabetes.
        Life Sciences. 1978; 23: 351
        • Hornstra G.
        • Haddeman E.
        • Don J.A.
        Some investigations into the role of prostacyclin in thromboregulation.
        Thrombosis Research. 1978; 12: 367
        • Johnson M.
        • Harrison H.E.
        • Raftery A.T.
        • Elder J.B.
        Vascular prostacyclin may be reduced in diabetes in man.
        Lancet. 1979; 1: 325
        • Larrue J.
        • Rigaud M.
        • Daret D.
        • Demond J.
        • Durand J.
        • Bricaud H.
        Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta.
        Nature. 1980; 285: 480
        • Moncada S.
        • Gryglewski R.J.
        • Bunting S.
        • Vane J.R.
        An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
        Nature. 1976; 263: 663
        • Moncada S.
        • Herman A.G.
        • Higgs E.A.
        • Vane J.R.
        Differential formation of prostacyclin (PGX or PGI ) by layers of the arterial wall. An explanation for the anti thrombotic properties of vascular endothelium.
        Thrombosis Research. 1977; 11: 323
        • Silberbauer K.
        • Schernthaner G.
        • Sinzinger H.
        • PizaKatzer H.
        • Winter M.
        Decreased vascular prostacyclin in juvenile-onset diabetes.
        N. Engl. J. Med. 1979; 300: 366
        • Sinzinger H.
        • Clopath P.
        • Silberbauer K.
        • Winter M.
        Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation?.
        Experientia. 1980; 36: 321
        • Whittle B.J.R.
        • Moncada S.
        • Vane J.R.
        Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
        Prostaglandins. 1978; 16: 373